These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1664831

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G, Intorre L, Bertini S, Soldani G.
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A, Martínez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M.
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of quinolones with special reference to the respiratory tree.
    Decré D, Bergogne-Bérézin E.
    J Antimicrob Chemother; 1993 Mar; 31(3):331-43. PubMed ID: 8486568
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics and biliary elimination of temafloxacin in pigs.
    Jehl F, Bresler L, Koechlin C, Merle-Melet M, Didelot JP, Hazebroucq J.
    J Antimicrob Chemother; 1992 Aug; 30(2):189-96. PubMed ID: 1328135
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparative penetration of lomefloxacin and other quinolones into human phagocytes.
    Perea EJ, García I, Pascual A.
    Am J Med; 1992 Apr 06; 92(4A):48S-51S. PubMed ID: 1316071
    [Abstract] [Full Text] [Related]

  • 33. The disposition of marbofloxacin in Eurasian buzzards (Buteo buteo) after intravenous administration.
    Garcia-Montijano M, Waxman S, Sánchez C, Quetglas J, San Andrés MI, González F, Rodríguez C.
    J Vet Pharmacol Ther; 2001 Apr 06; 24(2):155-7. PubMed ID: 11442792
    [No Abstract] [Full Text] [Related]

  • 34. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H, Richter WF, Hendrickx AG.
    Toxicol Appl Pharmacol; 1993 Sep 06; 122(1):34-45. PubMed ID: 8397453
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses.
    Flammer K, Aucoin DP, Whitt DA.
    J Vet Pharmacol Ther; 1991 Dec 06; 14(4):359-66. PubMed ID: 1663561
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS, Ramesh S, Ahmad AH, Tripathi HC, Sharma LD, Malik JK.
    Vet J; 2002 Jan 06; 163(1):85-93. PubMed ID: 11749141
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.